Danger Mouse is back saving London, saving the world and, most importantly, saving Penfold in brand new and fantastically absurd adventures.

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101. The ...

Moreover, a recent study by Tom Sidwell et al. on the developmental lineages of thymic Treg cells and transcription factor BAH2, revealed that loss of BACH2 enhanced the TCR- and IRF4-dependent ...